CO5590933A2 - Composicion y metodo para el tratamiento de la diabetes - Google Patents
Composicion y metodo para el tratamiento de la diabetesInfo
- Publication number
- CO5590933A2 CO5590933A2 CO04060289A CO04060289A CO5590933A2 CO 5590933 A2 CO5590933 A2 CO 5590933A2 CO 04060289 A CO04060289 A CO 04060289A CO 04060289 A CO04060289 A CO 04060289A CO 5590933 A2 CO5590933 A2 CO 5590933A2
- Authority
- CO
- Colombia
- Prior art keywords
- nucleotide sequence
- regulatory region
- detectable product
- diabetes
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/474—Pancreatic thread protein; Reg protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4733—Acute pancreatitis-associated protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
1.- Una secuencia de ácido nucleico aislada de la SEQ ID N°: 2).2.- Una secuencia indicadora caracterizada porque comprende:a. una secuencia de nucleótidos que codifica para un producto detectable; yb. una secuencia de nucleótidos de la región reguladora ligada al extremo 5AND#39 de la secuencia de nucleótidos que codifica para un producto detectable, caracterizada porque la secuencia de nucleótidos de la región reguladora comprende una o más regiones seleccionadas de los nucleótidos 1-3137 de la SEQ ID N°: 2).3.- Una secuencia indicadora de conformidad con la reivindicación 3, caracterizada porque además comprende:a. un elemento promotor intercalado entre la secuencia de nucleótidos de la región reguladora y la secuencia de nucleótidos que codifica para el producto detectable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32933001P | 2001-10-16 | 2001-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5590933A2 true CO5590933A2 (es) | 2005-12-30 |
Family
ID=23284879
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04031543A CO5570658A2 (es) | 2001-10-16 | 2004-04-02 | Composicion y metodo para el tratamiento de la diabetes |
CO04060289A CO5590933A2 (es) | 2001-10-16 | 2004-06-25 | Composicion y metodo para el tratamiento de la diabetes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04031543A CO5570658A2 (es) | 2001-10-16 | 2004-04-02 | Composicion y metodo para el tratamiento de la diabetes |
Country Status (20)
Country | Link |
---|---|
US (2) | US20040132644A1 (es) |
EP (1) | EP1435995A2 (es) |
JP (1) | JP2005506362A (es) |
KR (1) | KR20050036865A (es) |
CN (1) | CN1723034A (es) |
BR (1) | BR0213291A (es) |
CA (1) | CA2463769A1 (es) |
CO (2) | CO5570658A2 (es) |
CZ (1) | CZ2004479A3 (es) |
HU (1) | HUP0401612A3 (es) |
IL (1) | IL161073A0 (es) |
MA (1) | MA27503A1 (es) |
MX (1) | MXPA04003526A (es) |
NO (1) | NO20042012L (es) |
PE (1) | PE20030608A1 (es) |
PL (1) | PL370069A1 (es) |
RU (1) | RU2004114865A (es) |
SK (1) | SK1702004A3 (es) |
WO (1) | WO2003033808A2 (es) |
ZA (1) | ZA200402261B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037277A2 (en) * | 2002-10-24 | 2004-05-06 | Mcgill University | Use of ingap for reversing diabetes |
US20090142338A1 (en) * | 2005-03-04 | 2009-06-04 | Curedm, Inc. | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
WO2006096565A2 (en) * | 2005-03-04 | 2006-09-14 | Curedm Inc. | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
EA013821B1 (ru) * | 2005-05-25 | 2010-08-30 | Кьюрдм, Инк. | Проостровковые пептиды человека, их производные и аналоги и способы их применения |
EP1840573A1 (en) * | 2006-03-27 | 2007-10-03 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
US8785400B2 (en) * | 2006-11-22 | 2014-07-22 | Curedm Group Holdings, Llc | Methods and compositions relating to islet cell neogenesis |
MX2010002264A (es) * | 2007-08-30 | 2010-08-02 | Curedm Inc | Composiciones y métodos para utilizar péptidos proislet y sus analogos. |
WO2014052611A1 (en) * | 2012-09-27 | 2014-04-03 | Levetan Claresa | Generation of new pancreatic beta cells |
US20160039877A1 (en) | 2013-03-15 | 2016-02-11 | Shenzhen Hightide Biopharmaceutical, Ltd. | Compositions and methods of using islet neogenesis peptides and analogs thereof |
CN104045699A (zh) * | 2013-03-15 | 2014-09-17 | 深圳君圣泰生物技术有限公司 | 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物 |
CN104045698B (zh) * | 2013-03-15 | 2019-04-16 | 深圳君圣泰生物技术有限公司 | 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物 |
CN104045702A (zh) * | 2013-03-15 | 2014-09-17 | 深圳君圣泰生物技术有限公司 | 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物 |
CN103305457B (zh) * | 2013-06-06 | 2015-07-08 | 浙江省医学科学院 | 一种体外扩增胰岛β细胞的方法 |
US9321812B2 (en) * | 2014-03-28 | 2016-04-26 | Perle Bioscience | Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide |
US10829527B2 (en) * | 2016-03-10 | 2020-11-10 | Shenzhen Hightide Biopharmaceutical, Ltd. | Conjugates of islet neogenesis peptides and analogs, and methods thereof |
US20210196646A1 (en) * | 2018-08-15 | 2021-07-01 | Wake Forest University Health Sciences | Improved formulations for pancreatic islet encapsulation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US127624A (en) * | 1872-06-04 | Improvement in apparatus for elevating water | ||
US4658957A (en) * | 1985-01-28 | 1987-04-21 | Abbott Laboratories | Utility tray |
US6106840A (en) * | 1988-06-23 | 2000-08-22 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5834590A (en) * | 1995-02-22 | 1998-11-10 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Ingap protein involved in pancreatic islet neogenesis |
JP4111539B2 (ja) * | 1995-02-22 | 2008-07-02 | イースタン・ヴァージニア・メディカル・スクール・オブ・ザ・メディカル・カレッジ・オブ・ハンプトン・ローズ | 膵島新生に関与するingapタンパク質 |
ATE299888T1 (de) * | 1996-05-03 | 2005-08-15 | Abbott Lab | Antiangiogenische peptiden, dafür kodierende polynukleotide und verfahren zur hemmung der angiogenesis |
US6090577A (en) * | 1997-05-22 | 2000-07-18 | Incyte Pharmaceuticals, Inc. | Disease associated acidic protein |
US6986994B2 (en) * | 2001-01-09 | 2006-01-17 | Gmp Endotherapeutics, Inc. | INGAP displacement assays |
-
2002
- 2002-09-24 US US10/253,733 patent/US20040132644A1/en not_active Abandoned
- 2002-10-15 HU HU0401612A patent/HUP0401612A3/hu unknown
- 2002-10-15 CN CNA028201922A patent/CN1723034A/zh active Pending
- 2002-10-15 CA CA002463769A patent/CA2463769A1/en not_active Abandoned
- 2002-10-15 SK SK170-2004A patent/SK1702004A3/sk not_active Application Discontinuation
- 2002-10-15 EP EP02780465A patent/EP1435995A2/en not_active Ceased
- 2002-10-15 CZ CZ2004479A patent/CZ2004479A3/cs unknown
- 2002-10-15 RU RU2004114865/15A patent/RU2004114865A/ru not_active Application Discontinuation
- 2002-10-15 WO PCT/US2002/032904 patent/WO2003033808A2/en not_active Application Discontinuation
- 2002-10-15 PL PL02370069A patent/PL370069A1/xx not_active Application Discontinuation
- 2002-10-15 KR KR1020047005586A patent/KR20050036865A/ko not_active Application Discontinuation
- 2002-10-15 JP JP2003536523A patent/JP2005506362A/ja active Pending
- 2002-10-15 BR BR0213291-5A patent/BR0213291A/pt not_active IP Right Cessation
- 2002-10-15 MX MXPA04003526A patent/MXPA04003526A/es unknown
- 2002-10-15 IL IL16107302A patent/IL161073A0/xx unknown
- 2002-10-15 PE PE2002001014A patent/PE20030608A1/es not_active Application Discontinuation
-
2004
- 2004-03-23 ZA ZA200402261A patent/ZA200402261B/en unknown
- 2004-04-02 CO CO04031543A patent/CO5570658A2/es not_active Application Discontinuation
- 2004-04-09 MA MA27627A patent/MA27503A1/fr unknown
- 2004-05-14 NO NO20042012A patent/NO20042012L/no not_active Application Discontinuation
- 2004-06-25 CO CO04060289A patent/CO5590933A2/es not_active Application Discontinuation
-
2007
- 2007-12-04 US US11/999,208 patent/US20080171704A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0401612A3 (en) | 2006-04-28 |
CO5570658A2 (es) | 2005-10-31 |
SK1702004A3 (sk) | 2005-03-04 |
HUP0401612A2 (hu) | 2004-12-28 |
ZA200402261B (en) | 2004-09-28 |
EP1435995A2 (en) | 2004-07-14 |
CA2463769A1 (en) | 2003-04-24 |
US20080171704A1 (en) | 2008-07-17 |
IL161073A0 (en) | 2004-08-31 |
WO2003033808A3 (en) | 2003-09-18 |
NO20042012L (no) | 2004-07-16 |
JP2005506362A (ja) | 2005-03-03 |
RU2004114865A (ru) | 2005-05-27 |
MXPA04003526A (es) | 2004-07-22 |
US20040132644A1 (en) | 2004-07-08 |
MA27503A1 (fr) | 2005-09-01 |
KR20050036865A (ko) | 2005-04-20 |
WO2003033808A2 (en) | 2003-04-24 |
PE20030608A1 (es) | 2003-08-26 |
BR0213291A (pt) | 2004-10-26 |
CZ2004479A3 (cs) | 2005-01-12 |
PL370069A1 (en) | 2005-05-16 |
CN1723034A (zh) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5590933A2 (es) | Composicion y metodo para el tratamiento de la diabetes | |
CY1116385T1 (el) | Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β | |
CY1121580T1 (el) | ΝΕΟΙ ΠΡΟΑΓΩΓΕΙΣ β-ΑΚΤΙΝΗΣ ΚΑΙ RPS21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
DK289688D0 (da) | Ekspression af proapolipoprotein a-i. | |
DE69841105D1 (de) | Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion | |
DK1472344T3 (da) | Bakteriofaglysin | |
ECSP10010082A (es) | Udp-glucuronil transferasa y polinucleotido de codificacion | |
CY1111802T1 (el) | Πρωτεϊνη συμμετεχουσα σε αποκατασταση γονιμοτητας φυτου με κυτταροπλασματικη ανδροστειροτητα και γονιδιο που την κωδικοποιει | |
WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
EP1548107A4 (en) | CHROMOPROTEIN AND FLUOROPROTEINS | |
ATE196926T1 (de) | Gen grb3-3, variante und ihre verwendungen | |
ECSP11010938A (es) | Transferasa glucuronilo y un polinucleótido que codifica el mismo | |
ATE322545T1 (de) | Myrosinase aus brevicoryne brassicae | |
GB9320548D0 (en) | Improvements in or relating to organic compounds | |
ATE414156T1 (de) | Lipase-varianten | |
BR0002493A (pt) | Processo para a preparação de l-aminoácidos por fermentação e sequências de nucleotìdeos que codificam o gene accda | |
DE60230071D1 (de) | Methode für die herstellung von protamin | |
ES2552598T3 (es) | Hemocianina y secuencia de ácido nucleico que codifica para la misma | |
ES2271040T3 (es) | Factores especificos de hifa procedentes de candida albicans. | |
BRPI0412081A (pt) | aptámeros inibidores de catepsina g, uso de aptámeros inibidores de catepsina g, e, composição farmecêutica | |
SE0101519D0 (sv) | Nucleic ACID | |
BR0103900A (pt) | Processos para a preparação de piranos substituìdos | |
BRPI0307873A2 (pt) | sequência de nucleotídeo codificado um tolc, que contém uma sequência de aminoácido heteróloga | |
ATE517181T1 (de) | Rekombinante carboxypeptidase b | |
HUP0101805A2 (hu) | Humán dezadenilező nukleáz, ennek előállítása és alkalmazása |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |